Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALVO · against 588 other Healthcare companies listed in US-listed
Ranked #201 of 589 · scores higher than 65% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 40–49, including ALVO · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ALVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -13.7% | -4.3% | 30% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 2.6% | -0.8% | 60% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | -20.6% | -2.3% | 16% | 20% | |
| Book yieldHigher is better · 587 reported | -11.8% | 25.9% | 5% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 193 | 28.6B USD | 48 | 60 | |
| 198 | 7.0B USD | 47 | 63 | |
| 198 | 54.9B USD | 47 | 59 | |
| 198 | 155.7B USD | 47 | 64 | |
| 201 | 1.6B USD | 46 | 52 | |
| 201 | 1.26T USD | 46 | 62 | |
| 201 | 532M USD | 46 | 34 | |
| 201 | 40.2B USD | 46 | 73 | |
| 201 | 11.4B USD | 46 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score